Clinical Trial Update: Metformin for Treatment of Antipsychotic-induced Dyslipidemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating metformin for antipsychotic-induced dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Central South University | Conditions: Dyslipidemia | Phase 4 | Status: COMPLETED